7-147932395-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_014141.6(CNTNAP2):​c.2255+28674A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.705 in 152,094 control chromosomes in the GnomAD database, including 41,212 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.70 ( 41212 hom., cov: 32)

Consequence

CNTNAP2
NM_014141.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.608

Publications

6 publications found
Variant links:
Genes affected
CNTNAP2 (HGNC:13830): (contactin associated protein 2) This gene encodes a member of the neurexin family which functions in the vertebrate nervous system as cell adhesion molecules and receptors. This protein, like other neurexin proteins, contains epidermal growth factor repeats and laminin G domains. In addition, it includes an F5/8 type C domain, discoidin/neuropilin- and fibrinogen-like domains, thrombospondin N-terminal-like domains and a putative PDZ binding site. This protein is localized at the juxtaparanodes of myelinated axons, and mediates interactions between neurons and glia during nervous system development and is also involved in localization of potassium channels within differentiating axons. This gene encompasses almost 1.5% of chromosome 7 and is one of the largest genes in the human genome. It is directly bound and regulated by forkhead box protein P2, a transcription factor related to speech and language development. This gene has been implicated in multiple neurodevelopmental disorders, including Gilles de la Tourette syndrome, schizophrenia, epilepsy, autism, ADHD and intellectual disability. [provided by RefSeq, Jul 2017]
CNTNAP2 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AR, AD Classification: DEFINITIVE, NO_KNOWN Submitted by: ClinGen
  • cortical dysplasia-focal epilepsy syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Illumina, Labcorp Genetics (formerly Invitae), Orphanet, G2P, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.04).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.847 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_014141.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CNTNAP2
NM_014141.6
MANE Select
c.2255+28674A>G
intron
N/ANP_054860.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CNTNAP2
ENST00000361727.8
TSL:1 MANE Select
c.2255+28674A>G
intron
N/AENSP00000354778.3
CNTNAP2
ENST00000455301.2
TSL:3
n.190+28674A>G
intron
N/A
CNTNAP2
ENST00000627772.2
TSL:2
n.428+28674A>G
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.705
AC:
107122
AN:
151976
Hom.:
41195
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.364
Gnomad AMI
AF:
0.854
Gnomad AMR
AF:
0.800
Gnomad ASJ
AF:
0.887
Gnomad EAS
AF:
0.742
Gnomad SAS
AF:
0.770
Gnomad FIN
AF:
0.814
Gnomad MID
AF:
0.839
Gnomad NFE
AF:
0.853
Gnomad OTH
AF:
0.745
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.705
AC:
107175
AN:
152094
Hom.:
41212
Cov.:
32
AF XY:
0.706
AC XY:
52504
AN XY:
74340
show subpopulations
African (AFR)
AF:
0.364
AC:
15095
AN:
41434
American (AMR)
AF:
0.800
AC:
12237
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.887
AC:
3076
AN:
3466
East Asian (EAS)
AF:
0.743
AC:
3839
AN:
5170
South Asian (SAS)
AF:
0.770
AC:
3709
AN:
4816
European-Finnish (FIN)
AF:
0.814
AC:
8619
AN:
10582
Middle Eastern (MID)
AF:
0.833
AC:
245
AN:
294
European-Non Finnish (NFE)
AF:
0.853
AC:
58002
AN:
68014
Other (OTH)
AF:
0.747
AC:
1574
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1299
2598
3898
5197
6496
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
802
1604
2406
3208
4010
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.810
Hom.:
197912
Bravo
AF:
0.689
Asia WGS
AF:
0.729
AC:
2533
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
0.84
DANN
Benign
0.38
PhyloP100
-0.61
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2710091; hg19: chr7-147629487; API